Schedule 13D ownership disclosure

TENAX THERAPEUTICS INC

Security class unavailable · CUSIP: 88032L209

Event date: 2022-06-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-176644
Form type
SC 13D/A
Filer
ARMISTICE CAPITAL, LLC
CIK
CIK 1601086
Filed
Jun 17, 2022
Reporting period
Jun 10, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub